- 5 Results
Lowest price: € 170.92, highest price: € 372.66, average price: € 231.66
1
Stem Cells and Cancer (Cancer Drug Discovery and Development)
Order
at amazon.co.uk
£ 146.94
(aprox. € 170.92)
Shipment: € 5.581
OrderSponsored link

Stem Cells and Cancer (Cancer Drug Discovery and Development) - Paperback

2010, ISBN: 9781617379208

Editor: Bagley, Rebecca G. Editor: Teicher, Beverly A. Humana, Paperback, Auflage: Softcover reprint of hardcover 1st ed. 2009, 362 Seiten, Publiziert: 2010-12-16T00:00:01Z, Produktgruppe… More...

Shipping costs:Les coûts d'expédition peuvent différer des coûts réels. (EUR 5.58)
2
Stem Cells and Cancer (Cancer Drug Discovery and Development)
Order
at amazon.de
€ 198.98
Shipment: € 3.001
OrderSponsored link
Stem Cells and Cancer (Cancer Drug Discovery and Development) - Paperback

2010, ISBN: 9781617379208

Humana, Taschenbuch, Auflage: Softcover reprint of hardcover 1st ed. 2009, 364 Seiten, Publiziert: 2010-12-16T00:00:01Z, Produktgruppe: Buch, 1.88 kg, Pharmakologie, Medizin, Kategorien, … More...

Shipping costs:Les coûts d'expédition peuvent différer des coûts réels. (EUR 3.00)
3
Stem Cells and Cancer - Teicher, Beverly A. (Herausgeber); Bagley, Rebecca G. (Herausgeber)
Order
at Achtung-Buecher.de
€ 207.88
Shipment: € 0.001
OrderSponsored link
Teicher, Beverly A. (Herausgeber); Bagley, Rebecca G. (Herausgeber):
Stem Cells and Cancer - Paperback

2010

ISBN: 1617379204

Hardcover

Softcover reprint of hardcover 1st ed. 2009 Kartoniert / Broschiert Pharmakologie, Chromosom; DNA; Angiogenesis; Carcinoma; geneexpression; genes; transcription, mit Schutzumschlag 11, … More...

Shipping costs:Versandkostenfrei innerhalb der BRD. (EUR 0.00) MARZIES.de Buch- und Medienhandel, 14621 Schönwalde-Glien
4
Stem Cells and Cancer - Teicher, Beverly A. (Herausgeber); Bagley, Rebecca G. (Herausgeber)
Order
at Achtung-Buecher.de
€ 207.88
Shipment: € 0.001
OrderSponsored link
Teicher, Beverly A. (Herausgeber); Bagley, Rebecca G. (Herausgeber):
Stem Cells and Cancer - Paperback

2010, ISBN: 1617379204

Hardcover

Softcover reprint of hardcover 1st ed. 2009 Kartoniert / Broschiert Pharmakologie, Chromosom; DNA; Angiogenesis; Carcinoma; geneexpression; genes; transcription, mit Schutzumschlag 11, … More...

Shipping costs:Versandkostenfrei innerhalb der BRD. (EUR 0.00) MARZIES.de Buch- und Medienhandel, 14621 Schönwalde-Glien
5
Order
at alibris.co.uk
€ 372.66
OrderSponsored link
Bagley, Rebecca G. (Editor), and Teicher, Beverly A. (Editor):
Stem Cells and Cancer (Cancer Drug Discovery and Development) - Paperback

2010, ISBN: 9781617379208

Softcover, 352 pages. 10.20x7.70x1.00 inches., Nouveau livre, [PU: Humana Press]

Shipping costs:plus shipping costs Exeter, DEVON, Revaluation Books

1As some platforms do not transmit shipping conditions to us and these may depend on the country of delivery, the purchase price, the weight and size of the item, a possible membership of the platform, a direct delivery by the platform or via a third-party provider (Marketplace), etc., it is possible that the shipping costs indicated by find-more-books.com / find-more-books.com do not correspond to those of the offering platform.

Bibliographic data of the best matching book

Details of the book
Stem Cells and Cancer (Cancer Drug Discovery and Development)

Significance of Stem Cells to Tumor DevelopmentCancer stem cells remain a controversial topic and the criteria that define cancer stem cells are continuing to evolve. A recent surge in stem cell research has ignited a field of discovery into many human diseases including diabetes, neuropathologies, and cancer. By replacing specific differentiated cells that have either been lost or died, stem cell therapy proves to be a very promising approach to the treatment of many debilitating diseases. Though stem cells may provide therapeutic benefit under certain conditions, they are also often implicated in the initiation, progression, and therapeutic resistance of malignant disease. This first edition of Stem Cells and Cancer is intended to give a current perspective on the role of stem cells in cancer and strategies for novel therapies directed toward tumor stem cells. The current cancer stem cell hypothesis is presented in several chapters with distinctions made between the hierarchical and stochastic models of tumor cell development. "Stemness," self-renewal, pluripotency, clonality, and tumorigenicity are important concepts applied towards defining cancer stem cells. Signaling pathways such as Wnt, Sonic Hedgehog, Notch, and Bmi-1 that are involved in differentiation, proliferation, and survival are implicated in the malignant process. Additional chapters address the identification of cancer stem cell populations through the evaluation of molecular markers such as CD133, CD44, and CD24, for example, or by Hoescht dye exclusion to recognize 'side populations.' Mesenchymal and hematopoietic stem cells are described as well as mouse models that are employed to elucidate the properties and functionality of stem cells in cancer and the stem cell niche. This book encompasses a wide variety of human cancers that include but are not limited to leukemia, gliomas, breast, and prostate cancers. Resistance to conventional therapies, genetic versus epigenetic changes that affect therapeutic response and strategies to prevent disease recurrence are challenges have been incorporated into this volume. Stem Cells and Cancer represents a compendium of cutting edge research by experts in the field and will be instrumental in the study of this intriguing line of investigation for many years to come.Rebecca Bagley is a senior scientist at Genzyme Corporation and has worked in the biotechnology industry for 20 years with degrees in biology from Wellesley College and Harvard University. Her expertise in drug development spans a wide range of approaches including immunotherapies, gene and protein therapies, and small molecule delivery with publications in journals such as Molecular Cancer Therapeutics, Cancer Research, and Microvascular Research . Her current research focuses on stem cells, tumor vasculature, and target validation.Dr. Beverly A. Teicher is Vice President of Oncology Research at Genzyme Corporation. Dr. Teicher completed a PhD in Bioorganic Chemistry at the Johns Hopkins University and postdoctoral training at Yale University School of Medicine. Dr. Teicher joined Dana-Farber Cancer Institute as an Assistant Professor of Pathology and rose to Associate Professor of Medicine and Radiation Therapy, Harvard Medical School at Dana-Farber Cancer Institute and Joint Center for Radiation Therapy. Dr. Teicher is an active member of the international scientific community having authored or co-authored more than 400 scientific publications. She has edited eight books, is senior editor for the journal Clinical Cancer Research and is series editor for the Cancer Drug Discovery and Development book series.

Details of the book - Stem Cells and Cancer (Cancer Drug Discovery and Development)


EAN (ISBN-13): 9781617379208
ISBN (ISBN-10): 1617379204
Hardcover
Paperback
Publishing year: 2010
Publisher: Humana
364 Pages
Weight: 0,848 kg
Language: eng/Englisch

Book in our database since 2012-06-12T10:13:38-04:00 (New York)
Detail page last modified on 2023-06-08T17:02:23-04:00 (New York)
ISBN/EAN: 1617379204

ISBN - alternate spelling:
1-61737-920-4, 978-1-61737-920-8
Alternate spelling and related search-keywords:
Book author: bagley
Book title: stem cells and cancer stem cells, stem cell cancer cell


Information from Publisher

Author: Rebecca G. Bagley; Beverly A. Teicher
Title: Cancer Drug Discovery and Development; Stem Cells and Cancer
Publisher: Humana; Humana Press
346 Pages
Publishing year: 2010-12-16
Totowa; NJ; US
Printed / Made in
Weight: 0,851 kg
Language: English
213,99 € (DE)
219,99 € (AT)
236,00 CHF (CH)
POD
XVI, 346 p. 62 illus., 16 illus. in color.

BC; Cancer Research; Hardcover, Softcover / Medizin/Nichtklinische Fächer; Onkologie; Verstehen; Chromosom; DNA; angiogenesis; carcinoma; gene expression; genes; transcription; Pharmacology/Toxicology; Cancer Biology; Pharmacology; Pharmakologie; BB

Table of Contents Introduction – Cancer Stem Cells vs. Normal Stem Cells Rebecca Bagley, MS, Genzyme Corporation Chapter 1: Stem Cell Microenvironment – Hematopoietic Stem Cells Linheng Li, PhD, Stowers Institute for Medical Research Tannishtha Reya, PhD, Duke University Medical Center David Scadden, MD, Center for Regenerative Medicine, Mass General Hospital Sean Morrison, PhD, University of Michigan Medical School Chapter 2: Tumor Niche/Microenvironment – Mesenchymal Stem Cells Paul Simmons, PhD, University of Texas Health Science Center Ajeeta Dash, PhD, Genzyme Corporation Chapter 3: Cancer Stem Cells – Brain Tumors Peter Dirks, PhD, MD, University of Toronto Hospital for Sick Children Jeremey Rich, MD, Duke University Medical Center Nobuko Uchida, PhD, Stem Cells, Inc. Sheila Singh, MD, University of Toronto Hospital for Sick Children Chapter 4: Cancer Stem Cells – Breast Carcinoma Jane Visvader, PhD, Victorian Breast Cancer Research Consortium Max Wicha, MD, University of Michigan Comprehensive Cancer Center Michael Clarke, MD, Stanford University Stem and Regenerative Medicine Institute Connie Eaves, PhD, British Columbia Cancer Research Centre Chapter 5: Cancer Stem Cells – Lung Cancers Carla Bender Kim, PhD, Children’s Hospital/Harvard University Joan Schiller, MD, Southwestern Medical School/Simmons Comprehensive Cancer Center Jaclyn Hung, PhD, British Columbia Cancer Research Centre Chapter 6: Cancer Stem Cells – Pancreatic Cancer Diane Simeone, MD, University of Michigan Medical Center Chapter 7: Cancer Stem Cells – Ovarian Paul Szotek, MD, Mass General Hospital, Harvard Medical School Chapter 8: Cancer Stem Cells – Colon Michael Clarke, MD, Stanford University Stem and Regenerative Medicine Institute Hans Clevers,MD/PhD, Netherlands Institute for Developmental Biology Chapter 9: Cancer Stem Cells – Prostate Cancer Owen Witte/Susan Kasper Chapter 10: Epidermal Stem Cells Elaine Fuchs, PhD, Rockefeller University Fiona Watt, PhD, Cancer Resarch UK London, Cambridge Institute Chapter 11: Hematopoietic Stem Cells in Blood Cancers: Leukemia / Myeloma / Lymphoma Catriona Jamieson, MD/PhD, University of California Medical Center Daniel Tenen, MD, Beth Israel Deaconess Medical Center, Harvard Medical School Dominique Bonnet, PhD, London Research Institute Michael Becker, MD, University of Rochester Medical Center John Dick, PhD, Toronto General Research Institute Frederick Alt, PhD, Howard Hughes Medical Institute Michael Cleary, MD, Stanford University School of Medicine Irving Weissman, MD/PhD, Stanford University School of Medicine Craig Jordan, PhD, University of Rochester Medical Center Chapter 12: Epigenetic Control and Chromosomal Instability Laurie Jackson-Grusby, PhD, Children’s Hospital, Harvard Medical School Kornelia Polyak, MD/PhD, Dana-Farber Cancer Institute Bradley Bernstein, MD/PhD, Mass General Hospital, Harvard Medical School Stephen Baylin, MD, Johns Hopkins School of Medicine Chapter 13: Signaling Pathways Roeland Nusse, PhD, Stanford University Andreas Androutsellis-Theotokis, PhD, National Institute of Health Ivan Maillard, PhD, University of Pennsylvania School of Medicine Tannishtha Reya, PhD, Duke University Medical Center Linheng Li, Stowers, PhD, Institute for Medical Research Chapter 14: Targeting Cancer Stem Cells: A New Therapeutic Approach Tessa Holyoake, PhD, University of Glasgow D. Gary Gilliland, MD/PhD, Howard Hughes Medical Institute Jeffrey Molldrem, MD, M. D. Anderson Cancer Center Vera Donnenberg, PhD, McGowan Institute for

More/other books that might be very similar to this book

Latest similar book:
9781489982872 Stem Cells and Cancer (Majumder, Sadhan (Herausgeber))


< to archive...